Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Wilms Tumor × Alemtuzumab × Clear all

Sponsor

Conditions

Leukemia 27 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma 16 Myelodysplastic Syndromes 11 Hodgkin Disease 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Multiple Myeloma 7 Leukemia, Myeloid, Acute 7 Lymphoma, Non-Hodgkin 6 Lymphoma, Follicular 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, Mantle-Cell 5 Lymphoma, Large B-Cell, Diffuse 5 Leukemia, Myeloid, Chronic-Phase 5 Hematologic Neoplasms 5 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, B-Cell, Marginal Zone 4 Anemia, Aplastic 4 Waldenstrom Macroglobulinemia 3 Sezary Syndrome 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Mycosis Fungoides 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Extranodal NK-T-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Leukemia, Large Granular Lymphocytic 3 Immunoblastic Lymphadenopathy 3 Hematologic Diseases 3

Interventions

X-Rays 4 Phantoms, Imaging 4 Magnetic Resonance Spectroscopy 4 Specimen Handling 3 Radiotherapy 3 Nuclear Medicine Department, Hospital 3 Vincristine 2 Radiation 2 Doxorubicin 2 Dactinomycin 2 Carboplatin 2 Biopsy 2 ulixertinib 1 tipifarnib 1 thymoglobulin 1 tazemetostat 1 selpercatinib 1 sargramostim 1 pembrolizumab 1 palbociclib 1 olaparib 1 lorvotuzumab mertansine 1 larotrectinib 1 glutamic acid diethyl ester 1 etoposide phosphate 1 erdafitinib 1 cixutumumab 1 Vemurafenib 1 Surgical Procedures, Operative 1 Stem Cell Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡